Renowned Reproductive Medicine Clinic VCRM and INVO Bioscience Announce the Launch of the INVOcell™ Intravaginal Culture System in the Washington DC Metro Area

MEDFORD, Mass. and RESTON, Va., May 2, 2016

INVOcell™ is used for fertilization and early embryo development. Unlike conventional infertility treatments such as in vitro fertilization (IVF), where the eggs and sperm develop into embryos in a laboratory, INVOcell utilizes the woman's body as a natural incubator making it an in vivo procedure. The INVOcell procedure has a lower cost because it uses natural or low stimulation and is a more simplified procedure combined with a streamlined approach to medical management.  Yet, produces pregnancy and live birth rates similar to traditional IVF treatments. 

Dr. Sharara, Founder and Medical Director where the INVO treatment will be offered, commented, "We are very excited to offer the INVO treatment to our patients. Many of whom cannot afford to proceed with regular IVF and therefore are either left to undergo more failed IUI cycles or just drop out of treatment altogether. Some other couples feel that IVF is "not natural" or have moral or religious concerns with regular IVF, and INVO treatment is ideally suited for them. Recent data are very encouraging in that in good prognosis couples receiving the INVO treatment have success rates equal to those of traditional IVF. We believe that INVO treatment will allow couples who are struggling with emotional and financial issues an opportunity to become parents."

"There are an estimated 195,000 infertile couples in the Washington DC Metro Area that currently suffer from infertility.  The Center for Disease Control data shows that approximately 12,000 IVF cycles have been performed annually in the area leaving many patients untreated due to the cost of IVF," noted Katie Karloff, CEO of INVO Bioscience.  "Dr. Fady Sharara of the Virginia Center for Reproductive Medicine, now offering the INVOcell and INVO procedure, will be able to expand care to patients in the DC Metroplex area by providing a less expensive treatment with equivalent pregnancy rates to traditional IVF.  Dr. Sharara is the first physician to offer the INVO procedure in the Mid-Atlantic region of the U.S. as we continue to expand the offering of the INVO throughout the United States. This is very exciting for the company and promising to fertility patients.  INVO Bioscience is committed to rapidly delivering INVOcell through additional partnerships with physicians and through our own corporate facilities across the U.S."

About the Virginia Center for Reproductive Medicine

About Dr. Sharara: Dr. Sharara is a world-renowned expert in the field of Reproductive Endocrinology and Infertility. His practice (VCRM) is located in Reston, Virginia and has a reputation for consistently posting one of the highest success rates for ART on the East Coast. The clinic prides itself on its "boutique" setting along with its personalized and customized treatment plans. Dr. Sharara regularly treats patients from around the globe and the clinic has become the go-to place for many patients who have failed to achieve success at other fertility centers.

*A comparison of clinic success rates may not be meaningful because patient medical characteristics, treatment approaches, and entry criteria for ART may vary from clinic to clinic.